Agency
County of Stokes
County of Stokes was paid $1.20M by Medicaid between Jan 2018 and Dec 2024, across 27 billing codes. Its largest line is 99199, Unlisted special service, procedure or report — 79% of everything it billed.
33Billing provider infoCOUNTY OF STOKES
DANBURY, NC 27016
DANBURY, NC 27016
33aNPI1316914534assigned 03/07/2006
33bProvider typeCase Management Agency
28Total paid$1.20M
24GClaims183,568
24DCodes billed27
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Case Management Agency providers in North Carolina
Rank by total paid#118 of 195
Median peer was paid$2.05M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 748 | $20K | |
| 2019 | 981 | $26K | |
| 2020 | 807 | $22K | |
| 2021 | 21,983 | $153K | |
| 2022 | 44,625 | $254K | |
| 2023 | 49,557 | $285K | |
| 2024incomplete | 64,867 | $438K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99199 | Unlisted special service, procedure or report | 79% | 176,290 | 144,461 | $949K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 1,253 | 949 | $122K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.0% | 908 | 756 | $60K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.6% | 1,036 | 816 | $31K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,050 | 650 | $8K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 315 | 249 | $6K |
| 0012A | <1% | 82 | 74 | $4K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 159 | 124 | $3K |
| 0011A | <1% | 80 | 76 | $3K | |
| 0002A | <1% | 75 | 50 | $3K | |
| 0001A | <1% | 55 | 43 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 776 | 620 | $2K |
15 more codes
| 81025 | <1% | 228 | $1K | |
| 0071A | <1% | 26 | $793.92 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 35 | $617.13 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 141 | $519.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 30 | $409.19 |
| 90688 | <1% | 324 | $348.91 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 106 | $340.00 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 42 | $218.75 |
| 90734 | <1% | 67 | $111.36 | |
| 87210 | <1% | 17 | $46.56 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 26 | $21.59 |
| 91300 | 0% | 142 | $0.00 | |
| 91301 | 0% | 257 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 12 | $0.00 |
| 91307 | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARTIN, TAMMY (HEALTH DIRECTOR)